1. Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia. Issue 7 (7th June 2021) Authors: Fodil, S.; Raffoux, E.; Dumas, P. Y.; Desbrosses, Y.; Larosa, F.; Chantepie, S.; Larcher, M. V.; Mear, J. B.; Peterlin, P.; Hunault-Berger, M.; Hospital, M. A.; Morel, V.; Lucas, N.; Vidal, V.; Salanoubat, C.; Michel, J.; Mediavilla, C.; Ojeda-Uribe, M.; Alexis, M.; Frayfer, J. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 7(2021) Page Start: 1756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). (September 2016) Authors: Dupont, H.; Marolleau, J.P.; Totet, A.; Damiani, C.; Berceanu, A.; Larosa, F.; Bonhomme, J.; Chabrot, C.; Bouteille, B.; Boutoille, D.; Gastinne, T.; Peterlin, P.; Gari Toussaint, M.; Poisson, D.; Briet, D.; Buret, J.; Legrand, M.; Denis, B.; Raffoux, E.; Bergeron, A. Journal: Clinical microbiology and infection Issue: Volume 22:Number 9(2016) Page Start: 810.e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1760: A simple method for estimating the longitudinal isocentre shift due to gantry motion. (May 2017) Authors: Hudej, R.; Brojan, D.; Pulko, S.; Peterlin, P. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IAEA survey on image-guided radiotherapy protocols and doses in the European region. (December 2021) Authors: Peterlin, P.; Casar, B.; Jurković, S.; Gershkevitsh, E.; Pesznyák, C.; Vassileva, J. Journal: Physica medica Issue: Volume 92(2021)Supplement Page Start: S140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. On multichannel film dosimetry with channel‐independent perturbations. Issue 1 (17th December 2013) Authors: Méndez, I.; Peterlin, P.; Hudej, R.; Strojnik, A.; Casar, B. Journal: Medical physics Issue: Volume 41:Issue 1(2014) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment. (April 2017) Authors: Sebert, M.; Bally, C.; Peterlin, P.; Beyne-Rauzy, O.; Legros, L.; Gourin, M.P.; Sanhes, L.; Wattel, E.; Gyan, E.; Park, S.; Stamatoullas, A.; Laribi, K.; Banos, A.; Jueliger, S.; Chevret, S.; Ades, L.; Fenaux, P. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: APR 246 PLUS AZACITIDINE (AZA) IN TP53 MUTATED (M) MDS AND AML. LONG TERM FOLLOW UP OF PHASE 2 STUDY BY THE GFM. (September 2021) Authors: Cluzeau, T.; Sebert, M.; Rahmé, R.; Cuzzubbo, S.; Walter-Petrich, A.; Peterlin, P.; Recher, C.; Stamatoullas, A.; Willems, L.; Raffoux, E.; Berthon, C.; Sallman, D.; Ades, L.; Fenaux, P. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: EFFICACY OF CPX-351 AS FIRST LINE TREATMENT FOR HIGHER RISK (HR) MDS/CMML. A STUDY BY THE GFM. (September 2021) Authors: Peterlin, P.; Turlure, P.; Chevallier, P.; Gourin, M.-P.; Dumas, P.-Y.; Thepot, S.; Berceanu, A.; Park, S.; Hospital, M.-A.; Cluzeau, T.; Torregrossa-Diaz, J.-M.; Devron, L.; Sapena, R.; Chermat, F.; Dimicoli-Salazar, S.; Fenaux, P. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation -Bridging to transplantation: COMPARABLE OUTCOMES AMONG ADULT PATIENTS ALLOTRANSPLANTED FOR MYELODYSPLASTIC SYNDROME USING HAPLOIDENTICAL, MATCHED UNRELATED OR MATCHED SIBLING DONORS: A SINGLE-CENTER STUDY. (September 2021) Authors: Garnier, A.; Jullien, M.; Guillaume, T.; Peterlin, P.; Le Bourgeois, A.; Mahe, B.; Dubruille, V.; Blin, N.; Touzeau, C.; Gastinne, T.; Lok, A.; Vantyghem, S.; Moreau, P.; Bene, M.C.; Le Gouill, S.; Chevallier, P. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗